Stocks Weaker, Led by High-Beta Names
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Biotech Correction Nearing Support - Wells Fargo Survey (GILD) (CELG) (VRTX) (PCYC) (ITMN) (FPRX) (ARRY) (IBB)
March 26, 2014 10:24 AM EDTA survey of buyside investors suggested the biotech correction could find support soon, said Wells Fargo. Sentiment showed more downside may be likely but the sell off probably doesn't have much more steam.
"To gauge where sentiment lies following the recent biotech correction, we conducted a survey of investors. Based on the... More
